Literature DB >> 23461405

Attitude of Brazilian veterinarians in the recognition and treatment of pain in horses and cattle.

Sílvia E R S Lorena1, Stélio P L Luna, B Duncan X Lascelles, José E Corrente.   

Abstract

OBJECTIVE: The objective of this study was to assess the use of analgesics, describe the attitudes of Brazilian veterinarians towards pain relief in horses and cattle and evaluate the differences due to gender, year of graduation and type of practice. STUDY
DESIGN: Prospective survey.
METHODS: Questionnaires were sent to 1000 large animal veterinarians by mail, internet and delivered in person during national meetings. The survey investigated the attitudes of Brazilian veterinarians to the recognition and treatment of pain in large animals and consisted of sections asking about demographic data, use of analgesic drugs, attitudes to pain relief and to the assessment of pain. Descriptive statistics were used to analyze frequencies. Simple post hoc comparisons were performed using the chi-square test.
RESULTS: Eight hundred questionnaires were collected, but 87 were discarded because they were incomplete or blank. The opioid of choice for use in large animals was butorphanol (43.4%) followed by tramadol (39%). Flunixin (83.2%) and ketoprofen (67.6%) were the most frequently used NSAIDs by Brazilian veterinarians. Respondents indicated that horses received preoperative analgesics for laparotomy more frequently (72.9%) than cattle (58.5%). The most frequently administered preoperative drugs for laparotomy in horses were flunixin (38.4%) and xylazine (23.6%), whereas the preoperative drugs for the same surgical procedure in cattle were xylazine (31.8%) and the local administration of lidocaine (48%). Fracture repair was considered the most painful surgical procedure for both species. Most veterinarians (84.1%) believed that their knowledge in this area was not adequate. CONCLUSIONS AND CLINICAL RELEVANCE: Although these Brazilian veterinarians thought that their knowledge on recognition and treatment of pain was not adequate, the use of analgesic in large animals was similar in Brazil to that reported in other countries.
© 2013 The Authors. Veterinary Anaesthesia and Analgesia © 2013 Association of Veterinary Anaesthetists and the American College of Veterinary Anesthesia and Analgesia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23461405     DOI: 10.1111/vaa.12025

Source DB:  PubMed          Journal:  Vet Anaesth Analg        ISSN: 1467-2987            Impact factor:   1.648


  5 in total

1.  Validation of the Unesp-Botucatu composite scale to assess acute postoperative abdominal pain in sheep (USAPS).

Authors:  Nuno Emanuel Oliveira Figueiredo Silva; Pedro Henrique Esteves Trindade; Alice Rodrigues Oliveira; Marilda Onghero Taffarel; Maria Alice Pires Moreira; Renan Denadai; Paula Barreto Rocha; Stelio Pacca Loureiro Luna
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

2.  Clinical validation of the short and long UNESP-Botucatu scales for feline pain assessment.

Authors:  Maíra Belli; Alice R de Oliveira; Mayara T de Lima; Pedro H E Trindade; Paulo V Steagall; Stelio P L Luna
Journal:  PeerJ       Date:  2021-04-12       Impact factor: 2.984

Review 3.  Pain Management in Farm Animals: Focus on Cattle, Sheep and Pigs.

Authors:  Paulo V Steagall; Hedie Bustamante; Craig B Johnson; Patricia V Turner
Journal:  Animals (Basel)       Date:  2021-05-21       Impact factor: 2.752

4.  Validation of the UNESP-Botucatu unidimensional composite pain scale for assessing postoperative pain in cattle.

Authors:  Flávia Augusta de Oliveira; Stelio Pacca Loureiro Luna; Jackson Barros do Amaral; Karoline Alves Rodrigues; Aline Cristina Sant'Anna; Milena Daolio; Juliana Tabarelli Brondani
Journal:  BMC Vet Res       Date:  2014-09-06       Impact factor: 2.741

5.  An Investigation into the Perceptions of Veterinarians towards Perioperative Pain Management in Calves.

Authors:  Ria van Dyke; Melanie Connor; Amy Miele
Journal:  Animals (Basel)       Date:  2021-06-24       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.